Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01616056 · ClinicalTrials.gov registry record · Phase 2
Bandage Lenses in Treating Patients With Ocular Graft-Versus-Host Disease
A Phase 2 study, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT01616056 is a Phase 2 study that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 20 participants.
The verdict
NCT01616056, a Phase 2 study, has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
This phase II clinical trial studies how well bandage lenses work in treating patients with ocular graft versus host disease. Bandage lenses may be helpful in relieving eye symptoms and damage caused by eye graft versus host disease.
Interventions
- OTHER questionnaire administration
- BIOLOGICAL graft versus host disease prophylaxis/therapy
- PROCEDURE optical coherence tomography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2012-06 |
| Est. Completion | 2014-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01616056
The ClinicalTrials.gov registry entry for NCT01616056 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which questionnaire administration is the first listed.
NCT01616056 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01616056 about?
NCT01616056 is a clinical study titled "Bandage Lenses in Treating Patients With Ocular Graft-Versus-Host Disease". This phase II clinical trial studies how well bandage lenses work in treating patients with ocular graft versus host disease. Bandage lenses may be helpful in relieving eye symptoms and damage caused by eye graft versus host disease.
What is the current status of trial NCT01616056?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2012-06. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01616056?
The interventions under investigation include: questionnaire administration (OTHER), graft versus host disease prophylaxis/therapy (BIOLOGICAL), optical coherence tomography (PROCEDURE).
Who is sponsoring clinical trial NCT01616056?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.